Pharmaids Pharmaceuticals Ltd Share Price Today - Pharmaids Pharmaceuticals Ltd Stock Price Live NSE/BSE

Pharmaids Pharmaceuticals Ltd

NSE: BSE: 524572

₹32.01

(-3.58%)

Mon, 30 Mar 2026, 00:41 pm

MTF 5xInvest in Pharmaids Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap1.13B

PE Ratio0

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Pharmaids Pharmaceuticals Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
106.76
Net Profit
-13.51
P/B
4.08
Sector P/E
31.93
P/E
0
EV/EBITDA
0
Debt/Equity (Industry)
0.26
Interest Cover (Industry)
10.96
ROCE (Industry)
16.65
RONW (Industry)
14.66
ROE
0
ROCE
0
Debt/Equity
0.36
EPS (TTM)
0
Dividend Yield
0
Book Value
14.72
Interest Cover
-7.23

Analysis

all

Pros

Pharmaids Pharmaceuticals is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Pharmaids Pharmaceuticals has no debt, it does not need to be covered by operating cash flow.
Pharmaids Pharmaceuticals has no debt, it does not need to be covered by short term assets.
Pharmaids Pharmaceuticals's cash and other short term assets cover its long term commitments.
Pharmaids Pharmaceuticals has no debt compared to 5 years ago when it was 18.3%.

Cons

Unable to evaluate Pharmaids Pharmaceuticals's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Pharmaids Pharmaceuticals's dividend against the top 25% market benchmark as the company has not reported any payouts.
Pharmaids Pharmaceuticals has less than a year of cash runway if free cash flow continues to grow at historical rates of 32% each year.
Pharmaids Pharmaceuticals has less than a year of cash runway based on current free cash flow.
The average tenure for the Pharmaids Pharmaceuticals board of directors is less than 3 years, this suggests a new board.

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	32.99	32.99	5.14	5.22	5.22
FII	0	0	0	0	0
DII	0	0	0	0	0
Public	67.01	67.01	94.86	94.78	94.78
Government	0	0	0	0	0

Technical Analysis

RSI

30.18

MACD

-1.96

50 DMA

37.03

200 DMA

50.48

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	63.15	49.15	40.29	35.15	26.29	21.15	7.15
Fibonacci	49.15	43.80	40.49	35.15	29.80	26.49	21.15
Camarilla	35.29	34.01	32.72	35.15	30.16	28.87	27.59

Pivots Level: Classic

+28

63.15

+14

49.15

+5.15

40.29

35.15

Pivot Point

LTP: 27.67

-8.85

26.29

-14

21.15

-28

7.15

Moving Average

SMAEMA

Period

Value

10-EMA
31.24
20-EMA
32.70
30-EMA
34.07
50-EMA
36.60
100-EMA
41.57
200-EMA
47.55

Announcement Date	Purpose	Action
12 Feb 2026	board-meetings	Quarterly Results, Nine Months Results
01 Sept 2025	agm
28 Aug 2024	agm
06 Jan 2024	egm
29 Aug 2023	agm
06 Dec 2022	egm
26 Jul 2022	agm
20 Aug 2021	agm

Pharmaids Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd

Divis Laboratories Ltd

Lupin Ltd

Pharmaids Pharmaceuticals Ltd About

Pharmaids Pharmaceuticals engaged in the business of Contract Research, Development and Manufacturing services (CRDMO).

Industry

Pharmaceuticals - Indian - Formulations

Founded

1989

Headquarters

CEO

Shankarappa Nagaraja Vinaya Babu

Employees

Contact

Website

http://www.pharmaids.com

compliance@pharmaids.com

Phone

91-40-66669809

Location

4-4-211/212/3 1st Floor, Inderbagh Sulthan Bazar, Hyderabad, Telangana, 500095

Year	History
1989	The Company was incorporated as Pharmaids Pharmaceuticals Pvt Ltd, a Private Limited Company.
1992	The company was converted into a Public Limited company. A special resolution was passed under the Companies Act, 1956 on April 20.
2005	Pharmaids Pharmaceuticals signed an Ayurvedic drugs deal. The Company appointed Mr. Bipin Shah as the Chairman of the Company.
2024	The Company has entered into Share Purchase Agreement with two existing Public Shareholders of the Company. The Company has completed the Acquisition of 99.86% shareholding in Adita Bio Sys Private Limited.

Client Name	Order Side	QTY	Avg Price	Date
EPITOME TRADING AND INVESTMENTS	Buy	75000	32.45	19 Dec 2022
TOPGAIN FINANCE PRIVATE LIMITED	Buy	80000	32.42	19 Dec 2022
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED	Sell	94011	29.28	15 Dec 2022
TOPGAIN FINANCE PRIVATE LIMITED	Buy	52000	28.05	15 Dec 2022
EPITOME TRADING AND INVESTMENTS	Buy	60456	29.33	15 Dec 2022
BP EQUITIES PVT. LTD.	Sell	57806	29.49	14 Dec 2022
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED	Buy	94011	28.93	14 Dec 2022
EPITOME TRADING AND INVESTMENTS	Buy	100000	29.29	14 Dec 2022
BP EQUITIES PVT. LTD.	Buy	12	29.5	14 Dec 2022
RAVI KUMAR KROVVIDI	Sell	150000	12.1	26 Jul 2022

Pharmaids Pharmaceuticals Ltd News

Pharmaids Sells Step-Down Subsidiary for ₹3 Lakh

Pharmaids Pharmaceuticals completes divestment of step-down subsidiary Siri Labvivo Diet Private Limited to independent buyer Mr. Shivakumar B G for ₹3,00,000 consideration on March 27, 2026.

28 Mar 2026

companies

Pharmaids Subsidiary Gets A2LA Medical Device Testing Accreditation

Pharmaids Pharmaceuticals' material subsidiary Adita Bio Sys receives A2LA accreditation for medical device testing under ISO/IEC 17025:2017 standards and FDA GLP regulations.

24 Feb 2026

stocks

Pharmaids Board Meet Set for Feb 12 to Review Q3 Results

Pharmaids Pharmaceuticals has scheduled a board meeting on February 12, 2026, to consider and approve unaudited financial results for Q3FY26 and nine months ended December 31, 2025.

09 Feb 2026

co actions results

Pharmaids Independent Director Completes Term

Pharmaids Pharmaceuticals announces completion of Mr. Mopperthy Sudheer's independent directorship term effective January 05, 2026, leading to his cessation from board committees.

05 Jan 2026

stocks

Pharmaids Pharma Reconstitutes Board Committees

Pharmaids Pharmaceuticals Limited announces reconstitution of Audit Committee and Nomination & Remuneration Committee effective January 06, 2026, with new leadership structure.

05 Jan 2026

stocks

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800